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Abstract
Background: Dyspnea perception can be defined as a multidimensional experience of
breathing discomfort, influenced by physiological, psychological, social, and
environmental factors, that includes secondary psychological and behavioral responses
and cannot be defined only by physical objective abnormalities (Mularski et al., 2010).
Dyspnea is the most common and distressing symptom in patients with advanced lung
cancer and decreases one’s quality of life (QOL) (Smith et al., 2001). Furthermore,
dyspnea has been found to interfere with physical activities such as walking, work, and
psychological activities such as disposition, taking pleasure in life, relationship with
others, and sleep (Tanaka, Akechi, Okuyama, Nishiwaki, & Uchitomi, 2002). Thus, it can
be hypothesized that quality of life is related to perception of dyspnea in advanced lung
cancer patients; although no published reports have examined this relationship in this
population.
Objective: The purpose of this study was to examine the relationship between quality of
life and perception of dyspnea in a group of advanced lung cancer patients.
Method: This was a descriptive correlational, cross-sectional study. Quality of life was
measured using The Assessment of Quality of life at the End of Life (AQEL). Perception
of dyspnea was measured using the Cancer Dyspnea Scale (CDS). The participants were
22 patients in a hospice care setting diagnosed with advanced lung cancer that reported
dyspnea.
Results: The findings supported the literature review suggestions that there was indeed
relationship between the subscales, AQEL, and CDS measurement total scores. In the
sample of advanced lung cancer patients in the hospice care setting, results revealed the

AQEL subscales (basic function, activity, cognitive function an perception of care) had a
significant correlation to the AQEL total score. In addition, the physical symptoms (pain
and bowel movement) indicated a strong inverse relationship to the AQEL total score.
As indicated by prior research, analysis revealed the CDS subscales (discomfort, anxiety,
and sense of effort) had a strong significant relationship to the CDS total score.
Furthermore, it is important to note that the result geared toward the second aim of this
research study, indicated no significant relationships between the participants
demographics, AQEL total score, and CDS total score.
Implications: Increased knowledge of the relationship between quality of life and
perception of dyspnea in advanced lung cancer patients can provide a basis for the
development of more refined assessment tools, enhanced symptom management, and
overall improvement of the care of advanced stage lung cancer patients.
Conclusions: Precipitants of dyspnea included both physical and emotional sensations
triggered by immediate reactions connected to participants’ experience of dyspnea
perception amongst advanced lung cancer patients in the hospice setting.
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I

CHAPTER I

Statement of Problem and Rationale
Dyspnea is a common and distressing symptom in patients with lung cancer and it
decreases quality of life (QOL) (Smith et al., 2001). It has been acknowledged that this
symptom experience consists of several components such as intensity, frequency,
duration, affective impact, and the threat that is posed by this symptom (Dodd et al.,
2001). Dyspnea perception can be defined as a subjective, multidimensional experience
of breathing discomfort, influenced by physiological, psychological, social, and
environmental factors that includes secondary psychological and behavioral responses
and cannot be defined only by physical objective abnormalities (Mularski et al., 2010).
For lung cancer patients, living with an incurable disease means having to face the
idea of dying (Kahana, 2000). Feelings of loneliness and concern for those near and dear
influence the psychological impact experienced by lung cancer patients. Anxiety and
tension have a documented relationship with dyspnea exacerbation (Henoch, Bergman,
Gustafsson, Gaston-Johansson, & Danielson, 2007). Therefore, intensifying emotional
reactions to dyspnea, creates an unpleasant or troublesome feeling and causes stress,
creating worry and anxiety (Henoch et al., 2007). To the lung cancer patient, dyspnea is
a constant reminder of how serious the consequences of being stricken by a life
threatening disease are. Therefore, the psychological impact of both the dyspnea and this
disease creates a state of vigilance that instills a negative influence on concentration
resulting in the sufferer being restless, fearful, and physically weak (Henoch et al., 2007).
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Background and Significance
Lung cancer is a significant public health concern because it is the second most
diagnosed cancer and the number one cause of death among men and women in the
United States, accounting for more deaths each year than breast, prostate, and colon
cancers combined. It is estimated that 228,190 new cases will be diagnosed in the United
States in 2013; 118,080 among men and 110,110 among women. There will be an
estimated 159,480 deaths from lung cancer; 87,260 men and 72,220 women, accounting
for around 27% of all cancer deaths (American Cancer Society, 2013). Patients with
advanced lung cancer perceive physical symptoms as weakness and fatigue caused by
dyspnea, with much awareness of lost strength (Henoch et al., 2007). McCorkle and
Young (1978) defined symptom distress as the degree of discomfort reported by patients
in relation to his/her perception of the symptom being experienced. Dyspnea limits
activities and produces social isolation (Roberts, Thome, & Pearson, 1993).
Physiological impacts such as difficulty in breathing cause distress even in times of
relatively low occurrence. Patients perceive breathing as a symbol of life, with dyspnea
perceived as physically threatening, the feeling of inability to breathe creates an
overwhelming sensation that paralyzes one’s will to live. The physical aspect of this
symptom creates distress, a concept denoting physical implications beyond the current
moment (Tishelman et al., 2005).
It is well known that lung cancer is a leading cause of mortality and morbidity in
industrialized countries and potentially one of the most preventable cancers. The major
cause of this neoplasm is cigarette smoking. The U.S. government has made a concerted
effort to decrease tobacco use by passing legislative regulation and promoting
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educational efforts that resulted in significant reductions in the number of smokers,
decreasing the percentage of individuals who initiate the smoking habit, and increasing
the number of people who quit. Nevertheless, there is a wide recognition of the need to
address the issue of lung cancer prevention for those who are addicted to cigarettes or
who are exposed to lung carcinogens in other ways (Schachter & Neuman, 2007).
Lung cancer is a severe disease and has a limited survival rate (Henoch et al.,
2007). The most common symptom of dyspnea is caused by the underlying disease that
is usually the cancer tumor (Pan, 2003). The significance of this problem lies within the
complications and disease progression of lung cancer. As dyspnea creates a sensation of
uncomfortable awareness of breathing, it creates a frightening distressing experience in
patients with lung cancer (Pan, Morrison, Leipzig, Ness, & Fugh-Verman, 2000).
Physiologic measures such as pulmonary function tests and blood oxygen saturation
levels, do not necessarily correlate with the degree of dyspnea the individual is
experiencing (Bruera et al., 2003). Recently, the development of instruments that
measure the perception of dyspnea across such domains as sense of effort, anxiety, and
discomfort have provided researchers with a new means of assessing the individual’s
perception of dyspnea (Tanaka et al., 2000).
Since dyspnea is a subjective experience of difficult or uncomfortable breathing
(Kvale, Selecky, & Prakash, 2007), it is intuitive to conceptualize dyspnea as a complex
symptom in relationship to quality of life, including the physiological, psychological, and
social components of quality of life. Thus, it can be hypothesized that quality of life is
related to perception of dyspnea in advanced lung cancer patients, although no published
reports have examined this relationship in this population. This study was undertaken to
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explore the relationship between quality of life and perception of dyspnea in a group of
advanced lung cancer patients in a hospice setting.
Statement of Purpose
This study was proposed to help fill the gap in knowledge regarding quality of life
and dyspnea perception in the advanced lung cancer population. The overall purpose of
this study was to examine the relationship between quality of life and perception of
dyspnea in a group of advanced lung cancer patients.
The specific aims of this study were to:
1) Describe relevant demographic variables (age, race/ethnicity, educational level,
relationship status, income level), levels of quality of life, including its subscale
components (basic function, activity, emotional function, cognitive function, social
support, existential needs, perception of care), and levels of dyspnea perception,
including its subscale components (sense of effort, anxiety, discomfort).
2) Examine the relationship between relevant demographic variables, overall level of
quality of life, and overall level of dyspnea perception.
3) Examine the relationships between relevant demographic variables, the subscale
components of quality of life (basic function, activity, emotional function, cognitive
function, social support, existential needs, and perception of care) and the subscale
components of dyspnea perception (sense of effort, anxiety, and discomfort).
These specific aims addressed the following research questions in a group of
advanced cancer patients in a hospice setting:
1) What are relevant demographic variables (age, race/ethnicity, educational level,
relationship status, income level), levels of quality of life, including its subscale
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components (basic function, activity, emotional function, cognitive function, social
support, existential needs, perception of care), and levels of dyspnea perception,
including its subscale components (sense of effort, anxiety, discomfort)?
2) What are the relationships between relevant demographic variables, overall level of
quality of life, and overall level of dyspnea perception?
3) What are the relationships between relevant demographic variables, the subscale
components of quality of life (basic function, activity, emotional function, cognitive
function, social support, existential needs, and perception of care) and the subscale
components of dyspnea perception (sense of effort, anxiety, and discomfort)?
Conceptual Model
The theory of unpleasant symptoms (TOUS) is a middle-range theory that
includes elements believed to address the symptom experience and allows focus on either
multiple symptoms occurring together or a single symptom (Peterson & Bredow, 2013).
This theory consists of three major components: (1) physiological factors, (2)
psychological factors, and (3) situational factors, understood as the antecedents of the
symptom experience. Dyspnea as a symptom is the perceived indicator of change in
normal functioning as experienced by patients with advanced lung cancer. The TOUS
signifies the physiological factors, psychological factors, and situational factors that
influence the dyspnea symptoms, which can impact one’s perception of dyspnea in
relationship to the performance factors. The physical stress that dyspnea precipitates in
the human body, may occur at rest or with excursion. The feeling of shortness of breath,
tightness of the chest, inability to get air, or feeling of suffocation affects the patients’
survival factors in managing these symptoms (Dudgeon, Lertzman, & Askew, 2001).

Kamal, Maguire, Wheeler, Currow, and Abemethy (2011) indicated in their study the
relationship between physical symptoms of dyspnea and anxiety, particularly panic
attacks, is well documented. The associations between physiological, psychological,
situational, and performance factors in the advanced lung cancer population requires
much further study and elucidation, given the high prevalence of anxiety during end of
life care (Kamal, Maguire, Wheeler, Currow, & Abemethy 2011).
The Theory of Unpleasant Symptoms (TOUS) implies management of the
symptom will contribute to the management of other symptoms because patients with
advanced lung cancer do not experience dyspnea in isolation, but rather in conjunction
with other symptoms, concomitant stressors, and psychological existential distress;
dyspnea cannot be fully addressed unless these physical and nonphysical factors are
understood (Kamal, Maguire, Wheeler, Currow, & Abemethy 2011). Success is most
likely when, as many as possible of the patient’s individual dyspnea stressors and
associative symptoms (anxiety, depression, panic attacks) are identified and addressed.
This theory stresses symptoms may occur alone or together but when there are multiple
symptoms they often are not in synchrony (Lenz, Suppe, Gift, Pugh, & Milligan, 1995).
Thus, the TOUS is appropriate in guiding the proposed study of quality of life and
perception of dyspnea in a group of advanced cancer patients, as it provides a
multidimensional framework that includes physiological, psychological, and situational
factors that impact performance factors.
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Conceptual Model
Figure 1 The principles of Theory of Unpleasant Symptoms (TOUS) (Lenz et al., 1995).
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Figure 1. Middle-Range Theory of Unpleasant Symptoms
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Note. Adapted From “Collaborative Development of Middle-Range Nursing Theories:
Toward a Theory of Unpleasant Symptoms,” by E.R. Lenz, F. Suppe, A.G. Gift, L.C.
Pugh, and R.A. Milligan 1995, Advances in Nursing Science, 17(3), p. 10. Copyright
1995 by Lippincott Williams and Wilkins.
Theoretical Definitions
Dyspnea. The term dyspnea, has been defined by Merriam-Webster Collegiate
Dictionary (1993) as short of breath, difficult or labored respiration. As a word, it is
derived from ancient Greek; “dys” meaning disordered or abnormal and “pnoia” means
breath. Steadman’s Medical Dictionary for the Health and Professions and Nursing
(2012), defined dyspnea as shortness of breath, a subjective difficulty or distress in
breathing, usually associated with disease of the heart or lungs; occurs normally during
intense physical exertion or at high altitude. Current literature defines dyspnea as a
subjective, multidimensional experience of breathing discomfort, influenced by
physiological, psychological, social, and environmental factors, which includes
secondary psychological and behavioral responses and cannot be defined only by
physical objective abnormalities (Mularski et al., 2010). The American Thoracic Society
(1999) uses broad definition factors and states dyspnea is a subjective experience of
breathing discomfort that consist of qualitative distinct sensations that vary in intensity.
The sensation of dyspnea is a subjective phenomenon with physical, psychological,
social, and spiritual existential contributors. Therefore, there is no objective method for
measuring this phenomenon, much like pain; it is captured by patients' report (Thomas,
2009).
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Existing theory and studies of dyspnea as a symptom in the lung cancer
population had defined key attributes of dyspnea as frequency, intensity, and duration.
The quantification of dyspnea can be an important judgment in the severity and prognosis
in lung cancer patients. It can also lead to a limiting symptom that may be responsible
for the economic and social disabilities (Bass, 1990). Brown et al. (1986) found the
descriptions most frequently used by patients with lung cancer were difficulty breathing,
shortness of breath, air hunger, shallow respiration, and suffocation. Notably, 97% of
patients describe the chest as the location of their sensation, as well as an emotional
feeling accompanied by the sensation of anger, anxiety, and fear (Brown et al., 1986).
According to Rhodes and McDaniel (1999), the meaning people assign to physical
sensation of dyspnea may have profound implications for their physical and
psychological health and therefore, their QOL decreases. Roberts, Thome, and Pearson
(1993) found although dyspnea seems to be a significant symptom in advanced lung
cancer patients it often remains unmanaged by healthcare professionals.
Dyspnea is considered a most distressing symptom that can be attributed by
ascribing a positive and negative perspective on the symptom experience. How patients
perceive the impact of dyspnea on their daily lives can lead to situational meaning that
maybe triggered by inability to perform activities of daily living as a result of dyspneic
episodes (Armstrong, 2003). Existential meaning may incorporate the patient’s sense of
vulnerability and mortality as a result reminding them of their cancer diagnosis.
Therefore, the concept of dyspnea experience within the core of advanced lung cancer
patients may include attributes of dyspnea occurrence and distress as not only the
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physiological, psychological, and environmental, but also the situational existential
meaning or perception of individual suffering from dyspnea experience.
Perception. The term perception is defined as the process of attaining awareness
or understanding of sensory information Wikipedia (2008). The New Thesaurus defines
it as awareness, cognizance, consciousness, sense, concept, conception, idea, image,
notion, and thought (1995). In a concept analysis of this term, McDonald (2011),
concludes that perception is an individual landscape that could be a driving force for an
action on one’s view of processed information relating to past experience that creates
vision of the world looking through a filter of influences from sociocultural aspect of
humanity. Perception is never objective. It is an individual’s or group’s unique way of
viewing a phenomenon that involves the processing of stimuli and incorporates memories
and experiences in the process of understanding McDonald (2011). For the purpose of
this research study, dyspnea perception and QOL was explored to find the relationship
that describes awareness of the unique experiences of dyspnea symptoms as an individual
component of one’s perception that culminates comprehension of physiological,
psychological, and situational factors in advanced lung cancer patients.
Hui et al. (2013) examined the association among subjective rating of dyspnea
according to patients with advanced cancer, caregivers, nurses, and various physiologic
measures. The Edmonton Symptom Assessment Scale (ESAS) rating, causes of
dyspnea, vitals, and Respiratory Distress Observation Scale (RDOS) ratings were utilized
using a numeric rating scale (0=none, 10=worst). This study found patients’ expression
of dyspnea was strongly associated with caregivers’ assessment and patients’ own ESAS
dyspnea level. Findings from this study are consistent with the definition put forth by the
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American Thoracic Society, in which dyspnea is defined as “subjective experienced of
breathing discomfort that consist of qualitatively distinct sensations that vary in intensity.
The experience derives from interactions among multiple physiological, psychological,
social and environmental factors, and may induce secondary physiological and behavioral
response” (Parshall et al., 2012). Therefore, lack of correlation between dyspnea and
physiologic measures in this study put forth further research to better characterize the
major predictors of subjective dyspnea in relationship to qualitative distinct perception of
dyspnea in advanced lung cancer population in determining factors that contributes to the
overall dyspnea expression (Hui et al., 2013)
Quality of Life (POLL The term “quality of life” often is used interchangeably
with terms that have conceptually similar meanings, such as life satisfaction, well-being,
functional status, or happiness (Hass, 1999). In an analysis of this term, Hass (1999)
postulated life satisfaction, well-being, and happiness were subjective terms referring
solely to the achievement of an individual goal, while functional status is related to
externally evaluated performance task (McDaniel & Bach, 1994). Therefore, while each
of these terms could constitute a component of QOL, they do not fully explain or define
QOL in its entirety (Taylor, Gibson, & Franck, 2008). The key concept of QOL is
difficult to define, and currently no universally accepted definition exists in the health
care literature. Many authors agree on the subjective nature of global QOL which
includes multiple dimensions of the human experience. Thus, QOL is a multifaceted
phenomenon and has been conceptualized to include physical, psychological, social, and
spiritual dimensions (Hass, 1999; Stewart et al., 1999). The World Health Organization
(1997) provides a multi-dimensional definition that defines QOL as an individual’s
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perception of their position in life in the context of the culture and value systems in which
they live, in relation to their goal, expectations, standards, and concerns. For the
purposes of this study, the WHO definition of QOL as a broad-ranging definition concept
is used. Congruently, an underlying assumption of this study is QOL is affected in a
complex way by the person’s physical health, psychological state, and level of
independence, social relationships, personal beliefs, and their relationship to salient
features of their environment.
A longitudinal study of patients with advanced cancer (about 33% with lung
cancer) found symptom distress, functional status, and QOL began to decrease six
months prior to death and markedly decreased about two to three months prior to death.
As patients’ symptom distress increases, QOL decreases (Hwang, Chang, Fairclough,
Cogswell, & Kasimis, 2003). Patients with advanced lung cancer may be near the end of
life while receiving treatment or even on initial diagnosis. Although more men and
women in the United States die of lung cancer each year from breast, colon, and prostate
cancers combined (American Cancer Society 2010), limited research has been conducted
in this population, particularly when the cancer is advanced. QOL has been studied less
often in patients with lung cancer than in any other cancer populations, but research
available found patients with advanced lung cancer typically have a lower QOL than
patients with other types of cancer (Montazere, Gilis, & McEwan, 1998). Many studies
with patients with advanced lung cancer are clinical trials that focus on treatment
effectiveness and prediction of survival (Hermann & Looney, 2011). Although attention
to QOL in clinical trials has increased, little documentation of QOL assessment and
analysis exists in the health care literature (Tanvetyanon, Soares, Djulbegovic, Jacobsen,
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& Bepler, 2007), and high attrition (Bottomley, Efficace, Thomas, Vanvoorden, &
Ahmedzai, 2003). In addition, QOL often has been viewed in previous studies in a
narrow fashion and mostly as a secondary endpoint (Dooms & Vansteenkiste, 2004)
Thus, this study was designed to decrease the gap in knowledge regarding the sub
components of QOL and its relationship to perceived dyspnea.
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CHAPTER II
Literature Review
Physiological Factors
A study by Gupta, Braun, and Staren (2012) indicated QOL predictor improves
global health and physical function correlating with better survival. The first of two key
findings includes patient’s physical function and global health at baseline. It provided
prognostic information for survival after adjusting for the effects of age, gender,
treatment history, and tumor stage. The second key finding was an improvement in
physical function at three months in stage IV non-small cell lung cancer patient had a
potential indicator of improved patient survival. This finding suggested QOL
monitoring, coupled with treatment to improve global health and physical function when
indicated, should be investigated in prospective studies in non-small cell lung cancer.
Although some progress has been made with respect to the treatment of physical function
in cancer patients, clinical effectiveness remains inconsistent and unpredictable.
Furthermore, interventions aimed at improving physical functioning would be validated if
interventions enhance specific QOL. This challenges the cancer research enterprise to
develop greater understanding of the complex physiology responsible for all aspects of
QOL, and to use this information to develop more effective and predictable methods to
favorably modulate this critical aspect of patient health and wellness. As the
consequences of this study, physical function and global health are independent
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determinants of survival in non-small cell lung cancer and should be regularly assessed
and when indicated should be targeted for intervention (Gupta, Braun, & Staren, 2012).
Cai, Zhou, Yu, and Wan (2011) explored the level and predictors of the healthrelated QOL among patients who were newly diagnosed with lung cancer in China. A
descriptive survey was used to collect data from 108 patients. Their finding indicated
poor QOL in physical, psychological, social, and environmental domains utilizing the
World Health Organization Quality of Life Questionnaire (WHOQOL-BREF). This
might be related to the fact the patients were informed about their cancer diagnoses and
that in China, cancer often still is considered to be equivalent of a death sentence. Future
research in this study population should be directed towards investigating interventions
that are developed in response to physiological QOL issues. Such information could
advance the quality of healthcare, therefore could provide further direction regarding
improvement of psychophysical in relevant to QOL outcomes of patients with lung
cancer. Finally, it is important that further study should be conducted to fill the gap of
the importance of useful characteristic that healthcare providers must possess in order to
improve positive role in recognizing patients health and well-being (Cai, Zhou, Yu, &
Wan, 2011).
A perspective study of patients diagnosed with lung cancer who were treated at
home and at palliative care unit conducted by Leppert et al. (2011), examined the QOL
evaluation and the seriousness of lung cancer is associated metastasis and high
occurrence due to pollution, cigarette smoking, genetic factors, and poor prognosis. The
core questionnaires European Organization Research Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ-C30) along with the lung module EORTC QLQ-LC13 were
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used for the QOL assessment. From the 78 patients recruited, 58 completed the study: 12
patients general condition significantly deteriorated, 8 died, and 5 had brain metastasis.
Findings indicated lung cancer QOL is very important, especially in the advanced stage
of the disease when cure is not possible and patients had multiple symptoms. For the
majority of respondents, the EORTC QLQ-C30 symptom scale deterioration was
reported. This study had numerous limitations including cross-sectional design and small
sample size. The necessity of effective communication and the ability to fulfill the
questionnaires and the exclusion of patients with cognitive impairment and brain
metastasis were additional limitations. It seems early palliative care introduction,
effective symptom management, especially pain, dyspnea, fatigue, loss of appetite, and
constipation with psychosocial and spiritual support may significantly improve the
quality of life in patients with advanced lung cancer (Leppert et al., 2011).
Moore et al. (2002) assessed the effectiveness of nurse led follow up in the
management of patients with lung cancer. To measure their outcomes EORTC core
questionnaire about QOL were used. Findings of this study indicated follow up of
patients with lung cancer by clinical specialists is safe, acceptable, and cost effective.
Hence can lead to greater patient satisfaction and more appropriate and timely
interventions at the same or no greater cost, with no detriment to QOL. Notably, nurse
led follow up reduced the number of routine investigations and the burden on outpatient
resources and doctor’s time (Moore et al., 2002). The importance of this study and
management of patients with lung cancer is patients who receive interventions had less
severe episode of dyspnea, had better outcomes, and emotional functioning that leads to
overall improvement in patient’s QOL. The implications of this study in the scope of
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nursing practice and knowledge include the finding a nurse-led follow up enhanced care
across primary, secondary, and tertiary sectors reduces the burden on patients and acute
services. Healthcare providers’ satisfaction increased and the use of nurse led model of
care in this study led to an advantage of increased QOL for the patient and their loved
ones. Rather than going back and forth to the hospital, the patient has the comfort of
knowing he/she is being taken care of in his/her own safety net, which is his/her home
(Moore et al., 2002). Perhaps Moore et al. (2002) noted, replication at other centers in
the United Kingdom, with a range of nurse specialists and outside the context of a
research study is essential to support generalizable findings. The rate of attrition was high
because of death or disability, which attributed to difficulties with recruitment and
attrition are recognized problems of research studies conducted with very ill and dying
patients. The number of outcomes analyzed in this study would imply that some findings
might have occurred by chance. The primary outcome was assessed at three months; the
results from patients investigated at six and 12 months should be interpreted with caution.
The proposed study is designed to build upon to expand and enhance understanding of
the relationship between dyspnea and QOL in a group of lung cancer patients receiving
palliative care services.
Tishelman et al. (2007) conducted a study that examined symptom prevalence,
intensity, and association with distress in patients with advanced lung cancer (Tishelman,
Peterson, Degner, & Spragers, 2007). Their findings indicated breathing, pain, and
fatigue ranked as symptoms associated with most distress. Measurement assessments
used in this study were the European Organization for Research and Treatment of Cancer
QOL Questionnaire C30 (EORTC QLQ-C30), EORTC-LC13, and Thurston Scale of
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Symptom Distress (TSSD-LL). Authors found an association between the problem of
dyspnea and distress and argue there is a need for evidence-based palliative care to
support patients’ QOL (Sepulveda, Marlin, Yoshida, & Ullrich, 2002). Clearly, the
results in this study demonstrated it is likely the meaning attached to problems with
dyspnea for patients with advanced lung cancer may be an important factor influencing
their strong association with distress (Tishelman et al., 2007). These findings raised the
question as to whether the patients’ fears and anxiety about future symptom experiences
may be of clinical concern especially in situations in which better knowledge of and
access to palliative care may diminish unnecessary apprehension and suffering. Zabora,
Brintezenhofeszoc, Curbow, Hooker, and Paintadosi (2001) found patients with advanced
lung cancer to be at particular risk for psychological distress compared with other cancer
patient groups. The study that was conducted population raises awareness of the
importance of managing dyspnea as a distress symptom that further emphasized a need to
understand suffering as related to individual prioritization of QOL.
Psychological Factors
According to Henoch et al. (2008), patients’ experience of dyspnea included
triggering factors, bodily manifestation, immediate, and long-term reaction. Their study
indicated dyspnea can seldom be avoided and the trigger effects of this symptom among
patients, but the immediate reactions cannot, they are unconditional due to symptom
exacerbation on the basis of patient’s own perception. Their study provided an
opportunity to allow the patients to express the true meaning of breathlessness, their
disease progression, and what it means to live in a future where existential impact of
hope, hopelessness, and thoughts of death arises. This awareness resulted in the
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development of some strategies for managing dyspnea specifically the bodily strategies
of avoided bodily exertion, which they knew would provoke dyspnea (Henoch, Bergman,
& Danielson, 2008). The result of this study highlights the patients’ need of support and
acknowledgement of their worries about the future, which quite possibly can only occur
in the care model where there is a partnership with reciprocity and mutual inquiry
between a patient and a health care professional (Krishnasamy, Comer, Brendin, Plant, &
Bailey, 2001). However, Henoch et al.’s (2008) sample was small when comparing
dyspnea experience and strategies used, there were bodily, psychological, and existential
experiences but only bodily, including medical, psychological strategies. Consequently,
the existential impact was not met by any strategies by the patients. This discrepancy
needs to be acknowledged by healthcare professionals and could be addressed with
planned group sessions about life changes, QOL, and existential issues.
Teunissen, de Graeff, and Voest (2007) analyzed the relationship between
anxiety, depressed mood, and the presence and intensity of physical symptoms in 79
hospitalized patients diagnosed with advanced cancer. This study compared different
methods to measure anxiety and depressed mood on symptom presence and intensity.
The scale used for this study was the Hospital Anxiety and Depression Scale (HADS),
which is a simple, sensitive, and specific screening tool for psychiatric disorders in
hospitalized patients avoiding the inclusion of somatic symptoms. Results indicated in a
sample of terminally ill hospitalized cancer patients, it found high levels of anxiety and
depressed mood but no relationship with the presence of physical symptoms and only a
limited relationship with symptom intensity. This finding could have been due to the
course of illness trajectory and it is possible relationship between anxiety, depressed
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mood, and physical symptoms existed during the early stage of the disease. Further study
should be implemented to create a systemic screening for anxiety and depressed mood in
relationship to physical symptoms that is clinically relevant in advanced cancer patients
admitted for symptom control (Teunissen, de Graeff, & Voest, 2007).
Tanaka et al. (2002) studied the relationship between dyspnea and psychological
effects in advanced lung cancer patients. Their findings indicated dyspnea in advanced
lung cancer patients was significantly correlated with psychological distress, presence of
organic causes, cough, and pain. When such high prevalence of 55% considered to have
clinical dyspnea, it is in the interest of patients not to overlook psychological distress, to
detect it early, and to emphasize therapeutically appropriate interventions. The
intervention presented in the study was the appropriate use of assessments such as Cancer
Dyspnea Scale (CDS) and Hospital Anxiety and Depression Scale (HADS). In using
these assessments, healthcare providers can have a better understanding of the nature of
dyspnea. According to the study, management of dyspnea in advanced lung cancer
patients should be determined based upon the findings of this study that incorporates
interventions for the management of pain and psychological distress. This includes
psychotropic and psychological interventions for instance relaxation, which has been
reported to be effective in relieving dyspnea (Tanaka, Akechi, Okuyama, Nishiwaki, &
Uchitomi, 2002). This intervention can be applied to nursing practice to enhance the care
of both physiological, as well as psychological well being. However, several limitations
of Tanaka et al. (2002) study must be acknowledged including a cross-sectional design,
precluding the assessment of cause and effect, and the participants were ambulatory
outpatients; the results of this study may not apply to more severe dyspnea. The causal
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relationships between pain, psychological distress, and dyspnea need to be further
examined. A prospective study is needed to examine whether management of pain and
psychological distress, including psychotropic and psychological intervention such as
relaxation, which have been reported to be effective in relieving depression and anxiety,
is effective in relieving dyspnea. At this point, there are no current studies conducted
since the 2002 Tanaka study. The proposed study will examine the relationship between
dyspnea perception and QOL in a deeper manner.
Another study by Henoch et al. (2007) emphasized the impact of QOL in
relationship to symptoms, coping capacity, and social support in patients with lung
cancer. Their study clearly focused on the importance of symptom management, QOL,
and healthcare professional endeavors concerning this patient population. Baseline
measures used for this study were the Sense of Coherence Questionnaire (SOC), the
Medial Outcomes Study Social Support Survey (SSS), Assessment of QOL, and the End
of Life (AQEL), CDS, HAD, and the VAS to measure dyspnea intensity (VAS-D).
Findings indicated QOL and dyspnea deteriorated over time in patients with incurable
lung cancer. Significant deterioration was confined to sense of discomfort not only from
physical impairment, but also from psychological, social, and existential distress (Henoch
et al., 2007). Healthcare professionals should pay particular attention to this aspect of
dyspnea. Nursing practice should emphasize the importance of a multidimensional
approach to QOL assessment, as indicated in the conceptual definition and in research in
palliative care. This study reports using assessments such as AQEL, CDS, and HAD
helps healthcare practitioners identify the importance of dyspnea in relationship with
emotional functioning and aspect of coping capacity as an explanatory factor for the QOL
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experience in a palliative setting (Henoch et al., 2007). However, the limitation of this
study is 30% of the medically eligible patients declined to participate. Another problem
is patient attrition due to disease progression and death decreases the power of the
statistical analyses over time. Further studies are warranted to investigate the importance
of dyspnea and its components in terminally ill patients. It is encouraging to note that
coping capacity has a mitigating function and could be used in the design of interventions
to enhance QOL at the end of life.
Situational Factors
Situational factors included aspects of the social and physical environment that
may affect the individual’s experience and reporting of dyspnea symptom. Potentially
relevant social situational considerations include employment status, marital and family
status, social support, availability of and access to health care resources, and lifestyle
behaviors (Winningham, et al., 1994). The demographic tool utilized in this proposed
study encompasses the component of variables affecting situational factors. John (2010)
describes self-efficacy strategies used by lung cancer patients in relationship to the QOL
using a phenomenological approach. This qualitative study used a one-on-one semi
structured interview in assessing QOL and self-care strategies. Findings indicated family
and social support, functional independence, physical well-being, and spirituality is a
significant aspect of QOL. Perception of QOL is a highly individual experience that
documents the negative effects of fatigue on QOL during and after treatment for lung
cancer. Many of these strategies focus on managing the fatigue that has such a pervasive
negative effect on QOL; however, these strategies often are ineffective. Several
limitations exist in this study, for most being the small sample size, varying length of
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time since diagnosis, and treatment for lung cancer. These patients should be advised
about evidence-based strategies that might be more effective to manage symptoms and
improve their QOL, and these strategies should be tailored to fit the specific needs and
condition of the individual. Additional research also is needed about the roles of social
support and spirituality and promoting QOL.
Peterson and Ritz (2010) explored the interaction of self-awareness with fearful
beliefs about bodily sensation in relationship to increased attention towards self-leads to
move on-line processing of sensory information. Thirty participants were recruited
which included 11 males without any chronic respiratory disease or acute respiratory
problem. Participants completed two appointments in which attention were directed
either towards self or towards others. The Anxiety Sensitivity Index (ASI) was used as
the instrument to measure fear of bodily sensation and Hospital Anxiety and Depression
Scale (HADS) was used as the instrument to measure anxious and depressive mood.
Both instruments were utilized referring to any physical sensation to assess whether
negative mood or negative affect of specific body sensation would be more likely to
influence the effect of self-awareness on sensation ratings.
Findings conclude that self-awareness is a determinant of which self-related
information is greatly noticed. However, in a situation in which more and stronger
sensations are expected, such as in a laboratory setting or in daily life during exercise and
stress, over report was likely to occur than in situations, which has been labeled with no
bodily symptoms which are not expected. The authors also conclude that in such “safe”
situations, decision under external focus relied more on conservative strategies that led to
underreport. In addition, the awareness of what other thinks about self might be related
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to over-report or under report of sensations depending on salient implicit and explicit
social norms related to symptom report. It is clear that further emphasis and research in
this study should focus on one’s perception of self-awareness guided by external and
internal cues relative to individuals own cognitive factors, beliefs, and ways of coping in
relationship to certain situational factors that exacerbate breathing related sensations
which affects levels of self-awareness towards fearful belief about bodily sensations
guided by own individual perception (Petersen & Ritz, 2010).
Bachner and Carmel (2009) conducted a study assessing caregivers’ perceived
level of open communications about illness and death with their terminally ill relative and
examined the contribution of caregivers and situational variables to the explanation of
open communication. A total of 236 primary caregivers of terminal cancer patients
participated in this study. Communication was measured by 6 items into 1 factor, which
were composed of demographic variables, personality traits, and negative emotional
reactions to caregiving. The situational variables, included the duration and intensity of
caregiving, and perceived functioning and suffering of the patient. Structured
questionnaire was developed by the author based on the openness to discuss cancer in the
Nuclear Family Scale (Mesters et al., 1997). The questionnaire respectively elicited the
perceptions and feeling of caregivers regarding their interpersonal communication with
patients about both illness and approaching death during terminal stage as defined by the
last 3 months of the patient’s life. Sense of Coherence (SOC) also used to measure three
dimensions in which an individual sees the world as comprehensible, manageable, and
meaningful.
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Findings from this study indicated that caregivers rated their level of open
communication with patients about illness and death with a low rating. This result
showed that difficulties in communicating with their loved one’s about the illness and
death were avoided due to emotional burden attached by discussing death and illness.
One of the rationales could have been to protect patients to prevent further discomfort
and for caregivers to protect themselves from own fear of cancer diagnosis and death.
However, it is important to note that caregivers who have rated themselves with higher
self-efficacy have a tendency to be more communicative and open about the topic of
t

death and illness. Also, duration of caregiving was found to be a significant predictor to
open communications. Limitations discussed in this study include bias based on
caregiver’s grief experience as well as the death trajectory of the illness and the nature of
the cancer in which the patient died. The more caregivers are aware and involved in
patient’s death it becomes easier for them to discuss the dying process of their love one’s.
Further research should be explored to examine the association between caregivers’
characteristic and their level of open communication with patients. Special attention
should also be geared in assessing caregivers’ reaction to exhaustion and depression. In
doing so, deepening understanding of the mechanism behind these associations can
generate positive outcome in relationship to situational factors that affect the well being
of caregivers as well as patients (Bachner & Carmel, 2009).
Henoch, Axelsson, and Bergman (2010) conducted a study to further validate the
Assessment of the Quality of Life at the End of Life (AQEL) instrument compared to the
other widely used and validated Health Related Quality of Life (HRQL) instrument. One
hundred six patients with lung cancer receiving palliative care services in a Swedish
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Pulmonary Oncology Department completed the 20-item AQEL, the EORTC QLQ-C30,
Hospital Anxiety and Depression Scale (HADS), Sense of Coherence (SOC13), and
Social Support Survey (SSS). Findings indicated preliminary evidence of the validity of
the HRQL included the existential items. The scales were supported by multitrait scaling
such as basic function, activity, emotional function, cognitive function, and existential
needs. A social support scale was supported by principal component analysis that
resulted in a low internal consistency. This study concluded there was some evidence for
the validity of the AQEL, and its use was feasible with patients with cancer in palliative
care. However, additional work is needed to understand structure of the measure, as well
as its responsiveness to palliative intervention and clinical change in populations of
patients with cancer close to the end of their lives (Henoch, Axelsson, & Bergman, 2010).
Therefore, testing the feasibility and reliability of AQEL instrument in my chosen
population may be beneficial for the management of symptoms and maintenance of
quality of life in an individual’s life circumstances.
A study on the force of circumstances and impact of situational features and
personal characteristic on coping patterns across situations by De Ridder and Kerssens
(2003) quantified situational impacts in comparison to the impact of one’s personal
characteristics on the basis of symptom perception. There were 403 healthy participants
recruited to elicit coping response. Personal characteristics such as mental health, self
esteem, perceived social support, and dispositional coping style were assessed to identify
the situational features and personal characteristics that were responsible for situationrelated variance and person-related variance. Participants were given 20 brief evocative
descriptions of stressful situations depicting daily hassles that were systematically varied
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according to the situational features such as ambiguity, social context, and concern at
stake (De Ridder & Kerssens, 2003).
Results indicated that all three situational features proved to be significant
contributors that differentiate situation-specific coping patterns. This study assumed that
coping, as concerns, are considered to motivate coping by creating action-preparedness
while ambiguity and social context limits the possibility of options that can be applied in
a particular situation. It is clear that the role of situational features as relevant
determinants of coping response in a stressful situation can be a valuable complement for
future coping research. In doing so, an approach in which adaptive behavior can be
exclusively viewed as the expression of dispositional coping styles rather than to be taken
for granted on the basis of situational demands that may constraint coping preference.
Further research should be focused on specific insight to develop coping measures that
are tailored to the specific demand of stressors such as bereavement, chronic pain, and
cancer (De Ridder & Kerssens, 2003).
Summary of Literature Review
The articles reviewed suggest possible relationship between dyspnea and QOL.
Data from the articles reviewed probable association between dyspnea as a distress
symptom, increased morbidity, and a diminished sense of control, thus impacting QOL.
Hence, the patient’s attitude towards performance status given that QOL is as meaningful
as the actual length of life in patients with advanced lung cancer, which can be used in
clinical practice to systematically address QOL related problems throughout the treatment
course. The literature reviewed demonstrated a possible association between dyspnea
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perception and QOL, while elucidating a patient’s improved functional capacity enhances
a sense of control and normalities of one’s well being.
A significant gap in the literature reviewed is currently no published
interventional strategies have been tested to improve QOL in the advanced lung cancer
population. In the descriptive studies summarized above, relevant variables were often
not addressed, and poor performance patients were overrepresented among the non
participants. Consequently, very little documentation exists to provide a basis for the
development of effective interventional strategies. Thus, as a first step, the relationship
between dyspnea perception and QOL must be examined more closely as a basis for
planning more appropriate and timely interventions to enhance QOL in the dyspneic lung
cancer population.
Importance of Dissertation
Overall, the literature review clearly indicates much is needed to further our
understanding of dyspnea in relationship to quality of life in advanced lung cancer. At
present, the most commonly used intervention for dyspnea is supplemental oxygen and
medication (Henoch et al., 2007). Nursing research and randomized controlled studies
conducted in the United Kingdom support the use of nursing interventions such as
behavioral modification and psychosocial support. Behavioral interventions have been
the cornerstone of nursing interventions for many related symptoms, such as pain,
anxiety, and nausea. Anecdotally in the researcher’s experience, some dyspneic patients
with advanced lung cancer have benefitted from more effective breathing exercises.
Future directions for my research in this topic will be focused on developing a uniform
evidence-based clinical practice guideline for the management of dyspnea in advanced
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lung cancer. In addition, studies that incorporate symptom management and QOL in the
care of dyspneic patients are important issues in healthcare professionals’ endeavors and
it should be further explored. Other factors, such as coping capacity, can be hypothesized
to serve a mitigating function in decreasing dyspnea symptom distress and enhancing
QOL in the advanced lung cancer population. Data from the proposed study can form a
basis for future studies of other factors contributing to QOL in this population, ultimately
resulting in the testing of an intervention designed to decrease dyspnea while enhancing
QOL.
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CHAPTER III
Methodology
Specific Aims/Research Questions
The specific aims of this study were to:
1) Describe relevant demographic variables (age, race/ethnicity, educational level,
relationship status, income level), levels of quality of life, including its subscale
components (basic function, activity, emotional function, cognitive function, social
support, existential needs, perception of care), and levels of dyspnea perception,
including its subscale components (sense of effort, anxiety, discomfort).
2) Examine the relationship between relevant demographic variables, overall level of
quality of life, and overall level of dyspnea perception.
3) Examine the relationships between relevant demographic variables, the subscale
components of quality of life (basic function, activity, emotional function, cognitive
function, social support, existential needs, perception of care) and the subscale
components of dyspnea perception (sense of effort, anxiety, discomfort).
These specific aims addressed the following research questions in a group of
advanced cancer patients in a hospice setting:
1) What are relevant demographic variables (age, race/ethnicity, educational level,
relationship status, income level), levels of quality of life, including its subscale
components (basic function, activity, emotional function, cognitive function, social
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support, existential needs, perception of care), and levels of dyspnea perception,
including its subscale components (sense of effort, anxiety, discomfort)?
2) What are the relationships between relevant demographic variables, overall level of
quality of life, and overall level of dyspnea perception?
3) What are the relationships between relevant demographic variables, the subscale
components of quality of life (basic function, activity, emotional function, cognitive
function, social support, existential needs, perception of care) and the subscale
components of dyspnea perception (sense of effort, anxiety, discomfort)?
Research Design
A non-experimental, descriptive, correlational, cross-sectional design was
conducted to facilitate an understanding of the relationship between dyspnea perception
and QOL. A correlational study was appropriate at this beginning stage of understanding
the complex relationships between the factors contributing to dyspnea and QOL in the
advanced lung cancer population. In addition, correlational research helped investigators
establish a knowledge base for future research into casual inferences (Polit & Beck,
2012).

Setting
Participants were recruited through a hospice care agency distributing information
sheets to the clients upon admission to the hospice care setting with a diagnosis of
advanced lung cancer who reported dyspnea. A phone number was given for eligible
participants to call to receive information in which the study will be described. Potential
participants were given a consent form at the hospice setting for them to read, review,
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and discuss in which questions were answered at that time. All participants meeting the
eligibility criteria were given an IRB approved brochure describing the study.
Power Analysis
Power analysis is built on the concept of an effect size, which expresses the
strength of relationships among research variables. If there is a reason to expect the
independent and dependent variables will be strongly related, then a relatively small
sample may be adequate to reveal the relationship statistically (Polit & Beck, 2012). The
sample size of this study was decided by using an effect size, desired power, and an
acceptable significance level. According to Polit and Beck (2012), power analysis is
used to decrease the chances of Type II errors thus adding to the validity of the statistical
analysis by estimating how big the sample size should be. The effect size is the estimated
population effect size and this determines the magnitude of the relationships between the
independent and dependent variables. Therefore, based on a power analysis table, which
provides the estimated population correlation coefficient, alpha, and power, the required
sample size for a moderate size correlation coefficient (p = .40), an alpha of 0.05, and a
power of .80 are approximately 47 (Polit & Beck, 2012).
Sample
Purposive sampling was used to gather knowledge about the population to select
sample members. Researchers might decide purposely to select people who are judged to
be typical of the population or particularly knowledgeable about the issue under study.
The proposed sample study consisted of 22 patients in a hospice care setting diagnosed
with advanced lung cancer that reported dyspnea. Inclusion criteria are patients having
advanced lung cancer at stage IIIA or above and able to read, write and understand
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English. An exclusion criterion is severe mental or cognitive impairment. Attrition is
most likely to occur in this population due to death or disability, which will be addressed
during the 3 to 6 month data collection period by a 20% increase participants drawn from
the newly admitted lung cancer patients at Elizabeth Hospice Center (Polit & Beck). In
the case of advanced lung cancer patients, estimating sample size needs should be a
factor in anticipated loss of participants over time. Therefore, the researcher should
expect a certain amount of participant loss and recruit accordingly (Polit & Beck, 2012).
Operational Definitions
For the purposes of this study, perception of dyspnea qualities was measured by
the Cancer Dyspnea Scale (CDS) developed by Tanaka and colleagues (2000). The scale
measures three factors: 1) sense of effort; 2) sense of anxiety; and 3) sense of discomfort.
Quality of life will be measured by the Assessment of Quality of Life at the End of Life
(AQEL) scale, developed by Henoch et al (2010). This scale includes seven subscales:
basic function; activity; emotional function; cognitive function; social support; existential
needs; and perception of care.
Instruments
The CDS and AQEL consisted of a total of 33 questions answered by the
participants with the help of relatives or staff. The questions were answered at home and
in a nursing facility and at hospital. To minimize the burden on the participants,
questionnaires were given to the participants during the initial meeting with the primary
investigator. One week later, the primary investigator picks up questionnaires.
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Cancer Dyspnea Scale
The CDS consists of 12 items, with a 5-point scale ranging from 1 (not at all) to 5
(very much), which may be grouped into three factors according to the original validation
analysis (Tanaka et al. 2000). The factors include a physical factor called sense of effort
(5 items), a psychological factor called sense of anxiety (4 items), and a factor reflecting
the uncomfortable feeling at rest called sense of discomfort (3 items). The reliability and
validity of the CDS are presented in Table 1 below.
Assessment o f Quality o f Life at the End o f Life
The AQEL is a QOL assessment scale developed for palliative care and consists
of 20 questions across four basic domains (physical, psychological, social, and
existential.) The physical domain is assessed with the items: need to rest at daytime,
activities of daily living, strength, pain, nausea, bowel problems, and dyspnea (7 items).
The psychological domain is measured by memory, worry, insomnia, concentration, and
depression (5 items). The social domain is measured by sharing problems with family and
being regarded as usual by family and friends (2 items). The existential domain is
measured by ability to do what one wants, meaningfulness, and happiness (3 items). In a
subsequent, revised version (2000), the authors developed these domains into seven
subscales: basic function; activity; emotional function; cognitive function; social support;
existential needs; and perception of care. Initial assessment demonstrated a strong
correlation with the well-validated QLQ-C30 (Axelsson & Sjoden, 1999).
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Table 1.
Measurement Instruments

Variable

Instrument

Description

Reliability

Validity

Dyspnea
Perception

Cancer
Dyspnea
Scale (CDS)

12 items, with a 5point scale ranging
from 1 (not at all) to
5 (very much)

Cronbach’s alpha
coefficients were
0.83,0.81 and
0.94(Tanaka et al.,
2000)

Factors
significantl
y correlate
with VAS
r=0.57,p<0.
001
(Tanaka et
al., 2000)

Quality of
Life

Assessment
o f Quality of
Life at the
End o f Life
(AQEL)

QOL assessment
scale consisting of
20 questions about
QOL and one
complementary
question

The alpha
coefficient of
internal consistency
varied between
0.55 and 0.76
(Axelsson &
Sjoden, 1999)

AQEL
correlated
strongly
(r>.70)
with QLQC30
(Axelsson
& Sjoden,
1999)

Demographic
Form

Basic
Demographic
Information

age, race/ethnicity,
education level,
relationship status,
income level

N/A

N/A

Data Collection Procedures
The data collection and management processes were handled by the primary
investigator (PI). All data were retained and treated securely by the PI. Informed
consent, as required by the USD IRB committee and participating facilities, were
obtained from all participants. All participants understood this study is strictly voluntary
and confidential. Participant data were given numerical assignments during the
collection of data. The study began immediately following institutional review board
(IRB) approval from the University of San Diego (USD) and the hospice care setting
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facilities. Data were collected for analysis and stored in a secured and locked file cabinet
in the office of the PI.
Human Subjects
IRB approval was obtained from both the University of San Diego and
participating facilities. Participants received a copy of the informed consent and Bill of
Rights, which were reviewed and discussed with the participant prior to agreeing to
participate. During the recruitment process, participants had the opportunity for a
question and answer period to address the purpose, type of study, concerns, as well as
voluntary enrollment. Once questions were addressed to the participant’s satisfaction and
IRB approved consent form were provided for voluntary participation, and a signed copy
was given to the participant.
Data Management and Analysis
In order to achieve the specific aims of the study, the following data analysis
strategies were used for each specific aim as described below.
Specific Aim #1: Describe relevant demographic variables (age, race/ethnicity,
educational level, relationship status, income level), levels of quality of life, including its
subscale components (basic function, activity, emotional function, cognitive function,
social support, existential needs, perception of care), and levels of dyspnea perception,
including its subscale components (sense of effort, anxiety, discomfort).
Descriptive statistics were used for sample description and analysis, which is
intended to describe the sample characteristics. Frequency distributions are displayed
utilizing tables. The central tendency of the mean, mode, median, and standard deviation
were obtained and ranges examined.
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Specific Aim #2: Examine the relationship between relevant demographic variables,
overall level of quality of life, and overall level of dyspnea perception.
Spearman’s Rank and Pearson’s correlational analyses examined the relationship
between relevant demographic variables, overall level of quality of life, and overall level
of dyspnea perception Spearman’s Rank and Pearson’s correlational analyses examined
the relationships between relevant demographic variables, the subscale components of
quality of life (basic function, activity, emotional function, cognitive function, social
support, existential needs, perception of care) and the subscale components of dyspnea
perception (sense of effort, anxiety, discomfort).
Specific Aim #3: Examine the relationships between relevant demographic variables, the
subscale components of quality of life (basic function, activity, emotional function,
cognitive function, social support, existential needs, perception of care) and the subscale
components of dyspnea perception (sense of effort, anxiety, discomfort).
Pearson’s correlation coefficient described significant relationship between the
study variables. Pearson correlations coefficient (r) was used to determine association
among continuous variables; Spearman Rank correlation (r5) analysis was used to
establish a relationship between ordinal and continuous variables (Mertler & Vannatta,
2012; Munro, 2008; Polit, 2010). The value range for r is -1 to 1 with 0 having no
relationship between the variables. A positive r coefficient signifies direct relationship
where a negative r reveals an inverse relationship. The established p value is pre
determined at 05. SPSS 20.0 software was utilized to perform the analyses described
above.
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Strengths and Limitations of Methods
This quantitative study examined the relationship of quality of life at the end of
life and perception of dyspnea in a group of advanced lung cancer patients. This study
sought to test and validate theories that are presently constructed about how sometimes,
why phenomena happens. Dyspnea as a symptom, clearly impact one’s perceived QOL,
therefore, it was hypothesized that quality of life is related to perception of dyspnea. In
utilizing the quantitative methodology for this study, it provides strength in that they
produce answers when done correctly, that are solid, unlike an opinion on common sense
answer (Ratnesar & Mackenzie, 2006). Hence, some might argue there are limitations of
quantitative methods that tend to be difficult to read and understand, most especially the
statistical aspect of report, which can be technical and difficult to distinguish for an
average journal reader.
Study Limitations
Descriptive correlational study was used for sample description and relationship
relevancy for the proposed study. Correlational research is often efficient in collecting
much more data about a problem and is often strong in realism. Unlike many
experimental studies, correlational research is seldom criticized for its artificiality (Polit
& Beck, 2012). Notably, limitations of correlational research include difficulty of
interpreting correlational findings that stems, from the fact that in the real world,
behaviors, attitudes, and characteristics, are interrelated in a complex way. Therefore,
interpretations of most correlational results should be considered tentative, particularly if
the research has no theoretical basis and if design is cross-sectional (Polit & Beck, 2012).
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CHAPTER IV
This chapter provides a detailed analysis of research findings examining the
relationship of quality of life and perception of dyspnea in a group of advanced lung
cancer patients. A summary of the participant demographic and descriptive data is
presented in detail. The result of the study findings are organized around each of the
following aims:
Specific Aim #1: Describe relevant demographic variables (age, race/ethnicity,
educational level, relationship status, income level), levels o f quality o f life,
including its subscale components (basic function, activity, emotional function,
cognitive function, social support, existential needs, perception o f care), and
levels o f dyspnea perception, including its subscale components (sense o f effort,
anxiety, discomfort).
Specific Aim #2: Examine the relationship between relevant demographic
variables, overall level o f quality o f life, and overall level o f dyspnea perception.
Specific Aim#3: Examine the relationships between relevant demographic
variables, the subscale

components o f quality o f life (basic Junction, activity,

emotional function, cognitive function, social support, existential needs,
perception o f care) and the subscale components o f dyspnea perception (sense o f
effort, anxiety, discomfort).

40

Sample Description
The purposive study sample included 22 advanced lung cancer patients at stage
IIIA or above who reported dyspnea and were able to read, write, and understand
English. Data collection was done at the Elizabeth Hospice Center from January 2014 to
August 2014. The proposed original study was to include 47 participants, however due to
the severity of the illness such as cognitive decline, death and disability, and patient’s
refusal to participate, it lowered the number of eligible participants during the 8-month
period of data collection to 22 participants. In addition, there was low census of
advanced lung cancer patients during the data collection period, which played an
important role in regards to enrollment and attrition status in my study.
Descriptive Findings
Specific Aim #1: Describe relevant demographic variables (age, race/ethnicity,
educational level, relationship status, income level), levels o f quality o f life, including its
subscale components (basic function, activity, emotionalfunction, cognitive function,
social support, existential needs, perception o f care), and levels o f dyspnea perception,
including its subscale components (sense o f effort, anxiety, discomfort).
Characteristics of the sample included 54.5% female and 45.5% male. The
educational level ranges from 8th grade to PhD degree with the majority of 36.4% with a
high school degree. Relational status included single (13.6%), married (40.9%), divorced
(9.1%), and widowed (36.4%). Ethnicity/race included Caucasian (81.8%), African
American (4.5%), Hispanic Latino (9.1%), and Asian (4.5%). The average age in years
was 77 ±11.40 years old with a range of 50 to 90. The average annual income was
$40,000.00 ±$52,328.29 with a range of $0 to $250,000.00 (Table 2).
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Table 2.
Frequency Distributions for Demographic Information (N = 22)
Variables
Count
Percentage
Gender
Male
10
45.5%
Female
12
54.5%
Educational level
8th grade
2
9.15%
High School
8
36.4%
Some College
7
31.8%
BA
3
13.6%
MA
1
4.5%
Grad (PhD)
1
4.5%
Relational Status
Single
Married
Divorced
Widowed
Ethnicity/Race
Caucasian
African American
Hispanic Latino
Asian
Age in Years
50-69
70-79
80-89
90.00
Annual Income
.00
15000.00
20000.00
25000.00
28000.00
30000.00
35000.00
43000.00
45600.00

3
9
2
8

13.6%
40.9%
9.1%
36.4%

18
1
2
1

81.8%
4.5%
9.1%
4.5%

5
5
8
4

23%
23%
37%
18%

2
2
2
5
1
3
2
1
1

9.1%
9.15%
9.1%
22.7%
4.5%
13.6%
9.1%
4.5%
4.5%
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50000.00
120000.00
250000.00

1
1
1

4.5%
4.5%
4.5%

Assessment of the Quality of Life at the End of Life (AQEL)
The AQEL scores were calculated for 22 participants. Table 3 presents the
descriptive statistical results based on 20 questions about quality of life at the end of life.
Quality of life at the end of life was scored on a 1 - 10 scale. Overall, the AQEL score
mean revealed an approximate average level of quality of life at the end of life (M =5.55,
SD = .45). For Frequency Distribution for Assessment of Quality of Life at End of Life,
see appendix A
Table 3.
Descriptive Statistics for Assessment o f Quality o f Life at End o f Life (N = 22)
Mean ± SD
SE
Subscales
Basic Functions
5.63 ± 9.05
1.93
Activity
4.45 ± 2.28
0.49
Emotional Function
0.27
4.64 ±1.27
Cognitive Function
5.82 ±2.43
0.52
Social Support
5.45 ±1.94
0.41
Existential Needs
5.27 ±1.32
0.28
Perception of Care
9.66 ±0.52
0.11
Total Score
5.55 ± 0.45
0.10
Physical Symptoms
Q 4: Pain
4.48 ± 3.03
0.65
Q 5: Nausea
2.05 ± 2.40
0.51
Q 6: Bowel trouble
4.20 ±3.03
0.65
Q 7: Dyspnea
4.32 ±2.80
0.60
SD= Standard Deviation, SE=Standard error

Cancer Dyspnea Scale (CDS)
The CDS was used to measure dyspnea perception, which includes its subscale
components of discomfort, anxiety, and sense of effort. Table 4 presents the descriptive

statistical results based on the dyspnea scale which has a total of 12 items with a 5-point
scale ranging from 1 (not at all) to 5 (very much). The overall total mean score of CDS
revealed relatively mild perception of dyspnea (M= 14.27, SD = 7.64). Standard error
indicates 1.63 average error for a sample size of 22. For Frequency Distribution for
Cancer Dyspnea Scale, see appendix B
Table 4.
Descriptive Statistics for Cancer Dyspnea Scale and Subscales (N = 22)
Mean ± SD
SE
Subscales
Discomfort
Anxiety
Effort
Total Score

5.84 ±3.86
3.84 ±3.11
4.45 ±2.32
14.27±7.64

0.82
0.66
0.50
1.63

SD= Standard Deviation
SE=Standard error

Data Analysis and Research Questions
Specific Aim #2: Examine the relationship between relevant demographic variables,
overall level o f quality o f life, and overall level o f dyspnea perception.
There is no relationship between demographic variables, overall level of quality
of life, and overall level of dyspnea perception. However, data analysis revealed the
following trends. AQEL total score indicated females appears to have a slightly higher
level of QOL than males (r=.224,p = .32). In addition, CDS total score data analysis
indicated the following possible trends. As the patient becomes older they tend to have
higher level of dyspnea (r=326,p = .14) and married individuals experience less
dyspnea than single, divorced, widowed individuals (r=-.292,p = .19).

44

Specific Aim #3: Examine the relationships between relevant demographic variables, the
subscale components o f quality o f life (basic function, activity, emotional function,
cognitive function, social support, existential needs, perception o f care) and the subscale
components o f dyspnea perception (sense o f effort, anxiety, discomfort).
Demographics
Education and income had a strong significant relationship. The more educated
the participants were, the higher the level of income, (rs (1,20) = 0.58, p = 0.005).
Quality of Life Subscales
There was a positive correlation between educational level and AQEL existential
needs (rs (1,20) = 0.450,/? = .036). The higher the level of education the participants
attained, they report higher satisfaction in life’s meaning.
Physical Symptoms
There was a significant inverse relationship between pain and age. As the
participants aged they report less pain, (rs (1,20) = -0.511,/? = .015). There was a
significant inverse relationship between AQEL total scores and pain. The higher the
level of pain the participant experienced, the lower their overall quality of life, (rs (1,20)
= -0.449,/? = .036). There was a significant relationship between pain and cognitive
function. The higher the participants cognitive awareness are, the greater their level of
pain, (rs (1,20) = 0.483,/? = .023). There was a significant relationship between nausea
and cognitive function. The higher the level of nausea is, the higher the participants’
level of cognitive function, (rs (1,20) = 0.459,/? = .032). There was a significant
relationship between nausea and pain. The higher the level of nausea is, the higher the
participants’ level of pain, (rs (1,20) = 0.500,/? = .018).
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Quality of Life Total Score
Basic function was significantly related with the AQEL total score. The more
independent the participants were with activity of daily living (ADLs,) the higher their
overall quality of life, (rs (1,20) = 0..480,/? = 0.024). Activity was significantly related
with the AQEL total score. The higher degree of physical strength the participant had the
higher their overall quality of life, (rs (1,20) = 0.49, p = 0.020). There was a significant
inverse relationship between cognitive function and overall quality of life. As the
participants’ cognitive awareness declines, the QOL appears to increase, (rs (1,20) = 0.524, p = .012). There was a strong inverse significant relationship between perception
of care and the AQEL total score (rs (1,20) = -.603, p = .003). As participants’
perception of care increases their overall QOL decreases. There was an inverse
relationship between bowel movement and AQEL total score. As the difficulty of bowel
movements increased, the participants overall quality of life decreased, (rs (1,20) = 0.572,/? = 0.005).
Cancer Dyspnea Scale
There was a strong significant relationship between CDS anxiety and CDS
discomfort. The higher the level of anxiety is, the higher the participants’ level of
discomfort, (rs (1,20) = 0.823, p = .000).
Cancer Dyspnea Scale Total Score
There was a strong significant relationship between the CDS total score and the
CDS discomfort score, the higher the level of discomfort participants felt, the higher the
CDS total score, (rs (1,20) = 0.936, p = .000). There was a strong significant relationship
between CDS anxiety and CDS total score, the higher the level of anxiety the participants
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felt, the higher the CDS total score, (rs (1,20) = 0.882,/) = .000). There was a significant
relationship between the CDS sense of effort and CDS total score. The higher the
participants level of breathing effort, the higher their overall CDS total score, ( r s (1,20) =
0.456,/) = 0.033). (See Table 5 below for Correlation Matrix).
Table 5.
Spearman ’$ Rank Correlations Between Measures
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

(1) Age
(2)Education

-.034

(3)Income

.097

.580**

(4)AQEL
Total

.095

-132

-.312

(5)AQ Basic
Function

.157

.221

161

.480*

(6)AQ
Activity

-.060

-.250

-418

,490*

.035

(7)AQCog.
Function

-.350

.016

.381

-.524*

-.407

-.380

(8)AQ Exis.
Needs

-.017

.450*

.192

.041

-.017

-.206

-U S

.066

-.142

-.258

-603**

.059

.421

-.328

.030

-.511*

-.076

126

-449*

-.297

- 137

483*

-.064

-291

-.269

.158

.278

-.392

-.243

-.372

.459*

.021

-141

-500*

(12)AQ6
Bowel

.215

.320

.331

-.572**

-002

-235

-135

.349

-.253

.051

.021

(13)CDS
Discomf

.178

.237

.372

-.249

-.098

-.237

095

.002

.102

.126

.271

.115

(I4)CDS
Anxiety

.145

.172

-237

-.274

-140

.016

-011

.090

.169

285

130

.331

.823**

(15)CDS
Effort

052

101

-.210

-.088

-110

.054

.045

.253

-.233

.417

187

087

.298

.147

(16) CDS
Total Score

210

.295

-370

-.263

-.234

.093

.068

.154

.004

353

.222

.337

.936**

.882**

(9)AQ
Percept Care
(10)AQ4
Pain
(11)AQ 5
Nausea

Correlation is significant at the 0.01 level (2-tailed)
* Correlation is significant at the 0.05 level (2-tailed)

**

.456*
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Results Conclusion
The aims of this proposed study were formulated to address the research questions
of whether relationships existed between relevant demographic variables, the subscales
component of AQEL and CDS, and the total score for both the Assessment of Quality of
Life at the End of Life and the Cancer Dyspnea Scale. In the sample of advanced lung
cancer patients in the hospice care setting, results revealed that the AQEL subscales
(basic function, activity, and cognitive function) had a significant correlation to the
AQEL total score. This would be expected because the total AQEL score is derived from
the same items as are in the instrument’s subscales. In addition, the physical domain
(pain and bowel movement) indicated a strong inverse relationship to the AQEL total
score. Furthermore, it is important to note that the result geared toward the second aim of
this research study, indicated no significant relationships between the participants
demographics, AQEL total score, and CDS total score. However, examination of data
trends revealed possible relationships between some of the variables.
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CHAPTER V
Discussion
The primary purpose of this study was to examine the relationship between
quality of life and perception of dyspnea in a group of advanced lung cancer patients.
This study hypothesized that quality of life is related to perception of dyspnea as
indicated by hospice patients own bodily reaction and manifestation in strategies that
describes the triggering factors in relationship to QOL and their own dyspnea perception.
This chapter will provide detailed analysis and significance of the research findings as
well as discussion of strengths, limitations, and study implication that will guide future
directions of research findings on the basis of the outcome of the proposed study.
Demographics
The sample of 22 advanced lung cancer patients at stage IIIA or above
participated in this proposed study. Characteristics of the sample included 54.5% female
and 45.5% male. The educational level ranges from 8th grade to PhD degree with the
majority of 36.4% with a high school degree. Relational status included single (13.6%),
married (40.9%), divorced (9.1%), and widowed (36.4%). Ethnicity/race included
Caucasian (81.8%), African America (4.5%), Hispanic Latino (9.1%), and Asian (4.5%).
The average age in years was 77 ±11.40 years old with a range of 50 to 90. The average
annual income was $40,000.00 ±$52,328.29 with a range of $0 to $250,000.00. This
study was conducted in a setting where socio-economic status consisted of affluent
family and neighborhood that had a sufficient economic stability. As expected,
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socioeconomic status played an influential role in regards to ways of coping and adapting
into psychophysiological components of perceived burden of QOL. It is also important
to note that socioeconomic factors influence cancer risk factors such as tobacco use, poor
nutrition, physical inactivity, and obesity. Income, education, and health insurance
coverage influenced access to appropriate early detection, treatment, and palliative care
(Ward, et al., 2004).
The American Cancer Society (2014) recent report indicated lung cancer mainly
occurs in older people. About 2 out of 3 people diagnosed with lung cancer are 65 or
older; fewer than 2% of all cases found in people younger than 45, the average age at
time of diagnosis is about 70 years old (ACS, 2014). In comparison to my study
participants, it is about the same as the general assumption with the exception of 4
participants in their 90’s. This may be attributed to their higher social economic status,
which affords a higher level of health care.
Overview
As indicated by the literature reviewed conducted in this study, dyspnea is the
most prevalent symptom in patients with advanced lung cancer and it is supported by
decreased level of physical well being, psychological well being, and situational well
being (Zhou et al., 2009). Even though the level of dyspnea is generally assessed through
objective parameters that rely on respiratory function test such as arterial blood gasses
values, subjectively perceived dyspnea is not always consistent with objective dyspnea
indicators (Karapolat, et al., 2008). Therefore, this study recommends effects of dyspnea
in QOL should be thoroughly assessed in concurrent to objective indicators of dyspnea in
relationship to the subjective perception in the most accurate way in dealings with
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patients suffering from advanced lung cancer in a hospice setting. Hence, it is important
to note that most of the participants in this study had their own perception of dyspnea, as
described by their own physical features, involvement, and immediate reactions to their
environment, physical characteristics, and psychosocial state of mind. To date, the
possible long-term consequences of this study population, involves life changes with
limitations and dependence of their own QOL guided by existential reflection of
subjective meaning of dyspnea in relationship to the objective precipitation of dyspnea
symptoms.
Patient Sample
The vulnerability of the patients sample used for this study, constituted concerns
about cognitive status, inability to consent, response burden, measurement intrusiveness,
patients’ lack of time, complexity of research design, participants recruitment and
retention, diversity of the palliative care population, and involving others (hospice
personnel, patients themselves, family and caregivers) with such dilemmas, these led to
challenges most especially regarding participants recruitment and retention. Although,
the majority of the study participants met the logistic criteria for this research study, it is
essential to acknowledge terminally ill patient constitute a vulnerable group and
participants face more difficulties due to presence of multi-symptoms and severe
psychophysiological problem (Addington-Hall, 2007). Hence, Ferrell (2004) writes,
“There is no option to avoid research within the field of palliative care, as like all disease
areas, there is critical need to conduct research to advance the field. Improved care will
not happen without inquiry” (p. 408). Therefore, even if challenges and concern arises in
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this chosen population, both exquisite practicality and ethical dilemma of palliative
research must be conducted (Ferrell, 2004).
Assessment of Quality of Life at the End of Life (AQEL)
The overall AQEL score mean revealed an approximate average level of QOL at
the end of life (M=5.55, SD= .45). The overall AQEL total score indicated that more
than 50% of the participant reports a satisfactory quality of life at the end of life. Due to
the limited available research on the AQEL scale, all significant relationships between
AQEL total score, AQEL subscales, and AQEL physical symptoms were reported. The
subscale component of AQEL such as basic function and activity had a significant
relationship with the overall AQEL total score, indicating an increased level of
satisfaction with their physical well being. A negative relationship was also found
between cognitive function and total AQEL score. This indicated that as the participants
cognitive function declined their overall QOL appeared to increase. However, this would
be expected because the total AQEL score is derived from the items in the instrument’s
subscale item. Past literature found that when cognitive function declines, due to the
disease progression, it inhibits patients’ self report of their overall QOL. Therefore, it
appears as if the patient’s perception of OQL improved. Positive relationship is also
noted between existential need and educational level. The majority of the participants
perceive life’s meaning in relationship to happiness on the basis of educational attainment
and or life’s accomplishment. There was a strong inverse significant relationship
between perception of care and the AQEL total score. As participants’ perception of care
increases their overall QOL decreases. This indicates that with dependence of perceive
care participants QOL declines due to disease progression.
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The AQEL overall total score was also calculated for significance and
relationship with physical symptoms such as pain, nausea, bowel movement, and
difficulty breathing. Negative relationship was found between pain and age indicating
that as participant age they report less pain. This could be due to the trajectory of the
advanced lung cancer disease and metastasis to the brain, which declines cognitive
function that inhibits participant’s ability to report pain. Significant relationship was
found between pain and cognitive function indicating that the higher the participants
cognitive awareness, the greater their level of pain report. Negative relationship was also
noted between AQEL total score with pain indicating the higher the participant’s level of
k

pain, the lower their overall QOL. Negative relationship was found between bowel
difficulties and AQEL total score indicating as participants report higher difficulty with
bowel movements, their overall QOL decreases. Finally, a significant relationship was
found between nausea and cognitive function and nausea and pain. These indicate that
participant’s higher-level report of nausea relates to an increase of cognitive function and
self report of pain level.
Findings from the AQEL results are supported by past research conducted by
Henoch, Axelsson, and Bergman (2010). Their study gathered some evidence for the
validity of AQEL when used with palliative care patients. Relationships were found
among physical symptoms, existential need, basic function, and activity scales.
However, based on this proposed study, additional work is further needed and
recommended to understand the structure of the measure as well as its responsiveness to
palliative information and clinical changes in population of patients with advanced lung
cancer close to the end of life (Henoch, Axelsson, & Bergman 2010).

53

Cancer Dyspnea Scale (CDS)
The total mean score of CDS ( M - 14.27, SD = 7.64) indicated a relatively mild
perception of dyspnea among the study participants. However, a strong positive
relationship between CDS anxiety and CDS discomfort was noted, in addition to a strong
positive relationship between CDS total score, CDS anxiety, CDS discomfort, and CDS
sense of effort. This result concluded participants with increased level of physical and
emotional discomfort reported higher level of anxiety, which indicated difficulty of
breathing pattern. Findings from this study is supportive of Tanaka et al. (2002) which
discussed that dyspnea as perceived symptom is related to psychological distress which
has been reported to decrease QOL in patients with advanced lung cancer (Tanaka et al.,
2002). Further emphasis in psychosocial interventions, such as relaxation techniques and
visibility of social support from family care giver and hospice nurses should be explored
so that it can lead to improved reporting of perceived dyspnea among patients with
advanced lung cancer in the hospice setting.
Finally, in examining the relationship between relevant demographics variables,
overall level of quality of life, and overall level of dyspnea perception, notably there were
no significant relationships found. However, data analysis revealed the following
possible trends between AQEL total score and female participants indicating females
reported better QOL than males. This is contrary to study conducted by Weiner et al
(2002) their findings suggest that women with asthma report more symptoms, use more
rescue medications, experience poorer QOL, and are admitted to the hospital more
frequently than men. Their study suggested that because women seek more medical
attention and experience poorer QOL, women then actually experience greater discomfort
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to airflow obstruction than men. The fact that women report poorer quality of life than
men indicates that women’s perception of airway obstruction may be different than men
(Weiner et al., 2002). The possible reason female participants in this proposed study
might have reported better QOL than men could be due to the ratio of women more than
men, social and economical disparity, and participants educational level. Findings might
be different if study is conducted in diverse population. In regards to age and CDS total
score, it revealed that older participants reported higher level of dyspnea. The possible
explanation for this finding could be that aging process in cancer patients affects
precipitation of disease progression that leads to difficulty of breathing pattern. With
married people reporting less dyspnea than single, divorced, and widowed individuals,
literature reviewed for this study indicates that social support from your husband or wife
leads to better QOL and less disposition on physical impact of dyspnea pattern. It is
important to note however, that if the population afforded more participants, the results of
the correlations might reveal significance.
Summary
The aims of this proposed study were formulated to address the research questions
of whether relationships existed between subscales and total score for both the
Assessment of Quality of Life at the End of Life and the Cancer Dyspnea Scale in
relationship to QOL and perception of dyspnea in a group of advanced lung cancer
patients in a hospice setting. The results confirmed the literature review suggestions that
there was indeed some relationship between the subscales, AQEL, and CDS
measurement total scores. In the 22 sample participants of advanced lung cancer patients
in the hospice care setting, results revealed that the AQEL subscales (basic function,
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activity, and cognitive function) had a significant correlation to the AQEL total score. In
addition, the physical domain (pain and bowel movement) indicated a strong inverse
relationship to the AQEL total score. As indicated by prior research, analysis revealed
that the CDS subscales (discomfort, anxiety, and sense of effort) had a strong significant
relationship to the CDS total score. Furthermore, it is important to note that the result
geared toward the second aim of this research study, indicated no significant relationships
between the participants demographics, AQEL total score, and CDS total score.
However, examination of data trends revealed possible relationships between some of the
variables. Hence, the small sample size may have hindered the relevancy outcome of the
proposed study.
Research Strengths and Limitations
The strength of this descriptive study is it constituted an initial step in examining
the relationship between dyspnea perception and QOL in patients with advanced lung
cancer. The methods were validated via AQEL and CDS questionnaires in which the
relationship of quality of life and dyspnea perception encompasses the true meaning of
quality of life through psychological, physiological, and situational factors. This enabled
participants to minimize symptom burdens with one week given to complete the
questionnaires with the help of family or caregivers. The investigation of this
relationship, in a multidimensional way, served as a basis for future studies to develop
and test interventions to decrease dyspnea and enhance QOL in this population (GalloSilver & Pollack, 2000). The need to explore numerous interventions in lung cancer and
dyspnea is imperative. It is vital the healthcare team work therapeutically with patients
and family to help them live better with illness and its manifestations. In doing so, this
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forms a large part of the researcher’s role in educating nurses about dyspnea management
in lung cancer patients. All practitioners in hospice settings, who work with patients who
are dyspneic, would benefit from incorporating the interventions that was suggested in
the evidence-based practice research, or aspect of it, into their everyday clinical practice.
Thus, they can take the lead in implementing research interventions that further suits the
relationship of dyspnea perception with psychophysical aspects concurrently to improve
QOL.
The limitations of this study included its small sample size and the potential for
attrition due to disease progression and death. Thompson, Sola, and Cubrana (2005)
indicated although treatment advances have led to a steady increase in survival prognosis,
for the majority of patients, the average survival remains at about eight months from
diagnosis. Therefore, the need for high quality care to support patients and reduce the
devastating symptom of dyspnea is essential for early assessment and implementation of
psychophysical impact of dyspnea in relationship to QOL in a palliative care setting.
This study also met with some difficulties in terms of enrollment retention due to disease
progression and disease comorbidity. Severe cognitive decline were noted on potential
participants due to brain metastasis or increase dose of narcotic medication and severe
weakness and pain were also noted in patients with pre-existing diabetes, renal failure
and cardiovascular disease. This inhibited them from study enrollment. Lastly, the
population of this study was conducted in a setting consistent with an affluent
community. The majority of participants were Caucasian, married, have financial
stability, and good social support from friends and love one’s. This could have resulted
in a better reporting of OQL and dyspnea perception. Nevertheless, the analysis from this
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study yielded some interesting report in terms of symptom management in relationship to
physiological, psychological, and situational factors of perceived dyspnea in relationship
to QOL in advanced lung cancer patients in a hospice setting.
Implication for Nursing Practice
Quality of Life and perception of dyspnea in advanced lung cancer in a hospice
setting involves extensive exploration and adaptation when it comes to coping strategies
with individuals perceived difficulty of breathing leading to feeling of anxiety,
hopelessness, and fear of impending death (Twycross, Wilcock, & Stark-Toller, 2009).
The adapted conceptual theory of unpleasant symptoms (Lentz et al., 1995) guiding the
study supports nursing practice in understanding the concept of QOL in relationship to
perceived dyspnea symptom that affects the essential component in treating
breathlessness in an effort to improve patients’ QOL. Focusing on dyspnea perception,
functioning capacity, and psychosocial factors such as psychological distress and anxiety
will enable nurses in a hospice setting to determine the efficacy of a preventative
approach to reduce the burden of dyspnea in advanced lung cancer patients.
Nevertheless, dyspnea is a multidimensional construct commonly occurring with clusters
of other symptoms, requiring a multimodality approach. Therefore, nurses needs
continuing education that focuses on the multidisciplinary training combined with
involving opioids, dyspnea management, relaxation techniques, and psychometric
intervention that may yield to improving treatment of dyspnea as well as improving
quality of life in patients with advanced lung cancer.
Another factor this study identified is the effect of dyspnea on quality of life in
general, which appeared bothersome and interfered with every aspect of a person’s life

58

and being. Understanding this symptom from the participants’ perspective evoked
powerful images in the language they used to describe dyspnea (O’Drisscoll, Comer, &
Bailey, 1999). Many reported feelings of anxiety, fear, and panic during attacks of
dyspnea and some correlated this sensation to impending death. Therefore, plan of care
with a refined assessment tool must be considered most especially the functional and
psychosocial aspect of dyspnea, which examines quality of life issues that were
significant for each individual person. In doing so, this provides healthcare practitioner
with accurate assessment findings for the betterment of enhanced symptom management
as well as improve overall care of advanced lung cancer in a hospice setting.
Future Research
Practitioners involved in palliative care and end of life care need training in
interventions to improve dyspnea management in relationship to perceived breathlessness
and QOL (Froggatt & Walford, 2005). Although this study provided significant
relationships between QOL and perception of dyspnea, further research on a larger
diverse sample is needed to elucidate findings that clearly identify the true meaning of
perceived dyspnea and QOL. Diversity regarding socioeconomic status, ethnicity, and
race would be an important factor for future research since such characteristics may be
related to various responses to the QOL questionnaires as well as to the experience of
dyspnea. For example, Kwak and Haley (2005) identified racial differences in end of life
care and participants perception of care in a hospice setting. Their findings indicated that
perception of care such as pain and dyspnea were most likely unmet due to disparities in
end of life care the minority receives. Future studies would benefit in exploring diversity
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in understanding cause of racial differences in perception of dyspnea and QOL, well
being in advanced lung cancer population.
Notably, it is essential to consider that conducting research in patients who
require palliative care can be ethically challenging (Dorman et al., 2009). The nature of
dyspnea in the lung cancer population and the rapid decline towards death means it is
difficult to participate in clinical research (Booth, Moosavi, & Higginson, 2008).
However, despite this obvious dilemma, further studies involving development of course
specific to healthcare professionals with skills for patient assessment, meeting the
physiological, psychological, and social aspect of quality of life and dyspnea is greatly
needed to provide the best possible care and alleviate distress in this group of patients.
Conclusion
The study described the patients’ perception of dyspnea in relationship to QOL at
the end of life in advanced lung cancer population. Because patients do not experience
dyspnea in isolation but rather in conjunction with other symptoms, concomitant
stressors, existential distress, and dyspnea cannot be fully addressed unless these physical
and non-physical factors are understood (Kamal et al., 2012). This study investigated
physiological, psychological, and situational factors that influenced participants’ own
perception of dyspnea correlated with their own QOL status. Strong significance was
found among associative variables and certain components of AQEL instrument and CDS
measurement. The findings suggested precipitant of dyspnea included both physical and
emotional sensations triggered by immediate reactions connected to participants’
experience of perceived dyspnea. Acknowledging the importance in assessment of
dyspnea and its dramatic effects on independence and QOL can refine and improve our
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understanding of ability to recognize as well as the capacity to effectively treat this
disabling symptom.
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APPEN D IX A

Frequency Distributions for Assessment o f Quality o f Life at End o f Life (N = 22)
Count
Percentage
Cumulative
Percentage
Subscales
Basic Functions
1.50
3
13.6%
13.6%
3.25
1
4.5%
18.2%
3.50
1
4.5%
22.7%
4.00
3
13.6%
36.4%
4.50
2
9.1%
45.5%
5.00
1
4.5%
50.0%
5.50
1
4.5%
54.5%
6.50
1
4.5%
59.1%
6.75
1
4.5%
63.6%
7.00
2
9.1%
72.7%
7.50
1
4.5%
77.3%
9.00
2
9.1%
86.4%
9.25
1
4.5%
90.9%
9.50
2
9.1%
100.0%
Activity
1
4.5%
1.50
4.5%
4
18.2%
22.7%
2.00
1
4.5%
2.50
27.3%
2
9.1%
36.4%
3.00
2
9.1%
3.50
45.5%
3
13.6%
59.1%
4.00
1
4.5%
4.50
63.6%
3
13.6%
77.3%
6.00
1
4.5%
6.50
81.8%
2
9.1%
7.00
90.9%
1
4.5%
8.50
95.5%
1
4.5%
9.50
100.0%
Emotional Func
2.00
1
4.5%
4.5%
2.33
1
4.5%
9.1%
3.67
2
9.1%
18.2%
4.00
4
18.2%
36.4%
4.33
3
13.6%
50.0%
4.67
3
13.6%
63.6%
5.00
2
9.1%
72.7%
5.33
1
4.5%
77.3%
5.67
1
4.5%
81.8%
6.33
3
13.6%
95.5%
7.33
1
4.5%
100.0%
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Cognitive Function
1.00
2.00
3.50
4.00
4.50
5.00
5.50
6.00
7.00
7.50
8.00
8.50
10.00
Social Support
2.00
3.00
3.50
4.00
4.50
5.00
5.50
6.00
7.00
7.50
9.50
10.00
Existential Needs
3.50
4.00
4.50
5.00
5.50
6.00
6.50
9.50
Perception of Care
2.00
3.00
4.00
5.00

Count

Percentage

Cumulative
Percentage

2
1
1
1
2
1
1
3
2
3
3
1
1

9.1%
4.5%
4.5%
4.5%
9.1%
4.5%
4.5%
13.6%
9.1%
13.6%
13.6%
4.5%
4.5%

9.1%
13.6%
18.2%
22.7%
31.8%
36.4%
40.9%
54.5%
63.6%
77.3%
90.9%
95.5%
100.0%

1
2
1
1
2
3
5
2
2
1
1
1

4.5%
9.1%
4.5%
4.5%
9.1%
13.6%
22.7%
9.1%
9.1%
4.5%
4.5%
4.5%

4.5%
13.6%
18.2%
22.7%
31.8%
45.5%
68.2%
77.3%
86.4%
90.9%
95.5%
100.0%

2
3
3
3
5
2
3
1

9.1%
13.6%
13.6%
13.6%
22.7%
9.1%
13.6%
4.5%

9.1%
22.7%
36.4%
50.0%
72.7%
81.8%
95.5%
100.0%

14
3
3
2

63.6%
13.6%
13.6%
9.1%

63.6%
77.3%
90.9%
100.0%
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Total Score
4.50
5.00
5.13
5.15
5.20
5.30
5.45
5.55
5.65
5.70
5.78
5.85
5.90
5.95
6.30
6.53
Physical Symptoms
Q 4: Pain
1.00
2.00
3.00
4.00
4.50
5.00
6.00
7.00
8.00
9.00
10.00
Q 5: Nausea
1.00
2.00
3.00
4.00
8.00
10.00
Q 6: Bowel Diff.
1.00
3.00
5.00
6.00
7.00
8.00

Count

Percentage

Cumulative
Percentage

1
1
1
2
1
2
1
3
2
1
1
1
1
2
1
1

4.5%
4.5%
4.5%
9.1%
4.5%
9.1%
4.5%
13.6%
9.1%
4.5%
4.5%
4.5%
4.5%
9.1%
4.5%
4.5%

4.5%
9.1%
13.6%
22.7%
27.3%
36.4%
40.9%
54.5%
63.6%
68.2%
72.7%
77.3%
81.8%
90.9%
95.5%
100.0%

2
1
1
2
1
1
2
1
3
4
4

9.1%
4.5%
4.5%
9.1%
4.5%
4.5%
9.1%
4.5%
13.6%
18.2%
18.2%

9.1%
13.6%
18.2%
27.3%
31.8%
36.4%
45.5%
50.0%
63.6%
81.8%
100.0%

16
2
1
1
1
1

72.7%
9.1%
4.5%
4.5%
4.5%
4.5%

72.7%
81.8%
86.4%
90.9%
95.5%
100.0%

1
5
1
2
1
4

4.5%
22.7%
4.5%
9.1%
4.5%
18.2%

4.5%
27.3%
31.8%
40.9%
45.5%
63.6%
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9.00
9.50
10.00
Q 7: Dyspnea
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00

1
1
6

4.5%
4.5%
27.3%

68.2%
72.7%
100.0%

6
2
2
1
2
2
4
2
1

27.3%
9.1%
9.1%
4.5%
9.1%
9.1%
18.2%
9.1%
4.5%

27.3%
36.4%
45.5%
50.0%
59.1%
68.2%
86.4%
95.5%
100.0%
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Frequency Distributions for Cancer Dyspnea Scale and Subscales (N = 22)
Count
Percentage
Cumulative
Percentage
Subscales
Discomfort
.00
1
4.5%
4.5%
1.00
3
13.6%
18.2%
2.00
1
4.5%
22.7%
3.00
2
9.1%
31.8%
4.00
2
9.1%
40.9%
4.50
1
4.5%
45.5%
5.00
2
9.1%
54.5%
7.00
2
9.1%
63.6%
8.00
2
9.1%
72.7%
9.00
1
4.5%
77.3%
10.00
1
4.5%
81.8%
11.00
2
9.1%
90.9%
12.00
2
9.1%
100.0%
Anxiety
.00
4
18.2%
18.2%
1.00
4
18.2%
36.4%
2.00
1
4.5%
40.9%
3.00
1
4.5%
45.5%
4.00
2
9.1%
54.5%
5.00
2
9.1%
63.6%
6.00
3
13.6%
77.3%
7.00
3
13.6%
90.9%
8.00
1
4.5%
95.5%
10.50
1
4.5%
100.0%
Effort
.00
2
9.1%
9.1%
2.00
1
4.5%
13.6%
3.00
6
27.3%
40.9%
4.00
2
9.1%
50.0%
5.00
2
9.1%
59.1%
6.00
6
27.3%
86.4%
7.00
1
4.5%
90.9%
8.00
1
4.5%
95.5%
9.00
1
4.5%
100.0%
Total Score
.00
1
4.5%
4.5%
1.00
1
4.5%
9.1%
4.00
1
4.5%
13.6%
8.00
3
13.6%
27.3%
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9.00
13.00
14.00
15.00
17.00
17.50
19.00
21.00
22.00
23.00
25.00
29.50

1
2
3
1
1
1
1
1
1
1
1

4.5%
9.1%
13.6%
4.5%
4.5%
4.5%
9.1%
4.5%
4.5%
4.5%
4.5%
4.5%

31.8%
40.9%
54.5%
59.1%
63.6%
68.2%
77.3%
81.8%
86.4%
90.9%
95.5%
100.0%
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APPEN D IX C
University of San Diego
Institutional Review Board

Research Participant Consent Form
For the research study entitled:
Quality o f Life and Perception o f Dyspnea in Advanced Lung Cancer Patients

I. Purpose of the research study
Barbara A. Roces is a PhD nursing student at the University o f San Diego. You are invited to participate in
a research study he/she is conducting. The purpose o f this research study is: Examine die relationship
between quality o f life and perception o f dyspnea in a group o f advanced lung cancer patients.

II. What you will be asked to do
If you decide to be in this study, you will be asked to:

Complete three questionnaires that ask you questions about your age, race/ethnicity,
relationship status, educational level, income level, levels of quality of life, including its
subscale components (basic function, activity, emotional function, cognitive function,
social support, existential needs, perception of care), and levels of dyspnea perception,
including its subscale components (sense of effort, anxiety, discomfort).
Your participation in this study will take a total of 45 minutes.

III. Foreseeable risks or discomforts
a) Sometimes when people are asked to think about their feelings, they feel sad o r anxious. If you
would like to talk to someone about your feelings at any time, you can call toll-free, 24 hours a day:
San Diego M ental Health Hotline a t 1-8041-479-3339

IV. Benefits
While there may be no direct benefit to you from participating in this study, the indirect benefit of
participating will know that you helped researchers better understand the relationship between quality of
life and perception o f dyspnea in a group o f advanced lung cancer patients.

V. Confidentiality
Any information provided and/or identifying records will remain confidential and kept in a locked file
and/or password-protected computer file in the researcher’s office for a minimum o f five years. All data
collected from you will be coded with a number or pseudonym (fake name). Your real name will not be
used. The results o f this research project may be made public and information quoted in professional
journals and meetings, but information from this study will only be reported as a group, and not
individually.

VI. Compensation
a) If you participate in the study, the researcher will give you a $15 W all-M art gift card in the
following way: (personally.)
You will receive this compensation even if you decide not to complete the entire questionnaire.

VII. Voluntary Nature of this Research

79

Participation in this study is entirely voluntary. You do not have to do this, and you can refuse to
answer any question or quit at any time. Deciding not to participate or not answering any o f the questions
will have no effect on any benefits you’re entitled to, like your health care, or your employment or grades.
You can w ithdraw from this study a t any time w ithout penalty.

VIII. Contact Information
If you have any questions about this research, you may contact either:
1) B arbara A. Roces
Em ail: broces@sandiego.edu
Phone: (323) 533-0924
2) D r. Jane Georges
Em ail: jgeorges@sandiego.edu
Phone: (619) 260-4566
I have read and understand this form, and consent to the research it describes to me. I have received
a copy of this consent form for my records.

Signature of Participant

Date

Name of Participant (Printed)

Signature of Investigator

Date
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A P P E N D IX D

AppertJ \ x \

Ann Sturtey, DrPH, RN, BSN. CHPN
Education Manager
The Elizabeth Hospice
500 La Terraza Blvd., Suite 130
Escondido. CA 92025
October 14,2013
Jane Georges PhD. RN
Dissertation Chair
University of San Diego
Hahn School of Nursing and Health Science
5998 Alcala' Park
San Diego, CA 92110
Re: Barbara A. Roces
Dissertation Study Site
Dear Dr. Georges:
We are pleased to inform you that we have approved your doctoral student
Barbara A. Roces to conduct her dissertation study at Elizabeth Hospice on
Quality of Life and Perception of Dyspnea in Advanced Lung Cancer Patients.
We look forward to her research contribution to nursing science. Please feel
free to contact me at (760) 737-2050 x 2508 if you have any questions.
Sincerely.

Ann Sturtey, DrPH, RN, BSN, CHPN
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APPEN D IX F
10/ 1 7 /1 4

T h e U n iv e r s ity o f S a a D i e g o M a i l - !% D N u r s i n g D o c t o r a l S to d y

/A University* San Diego*

PhD Nursing Doctoral Study
Barbara Room <broc88Qsandieao.edu>
To: bertil.axeissonQiH.se

Mon, Oct 7, 2013 at 8:04 PM

Dear Mr. Axeisson,
My name is Barbara A. Roces a 3rd year PhD student in Nursing at University of San Diego. I'm interested in
using the Assessment of Quality of Life at the end of Life (AQEL) for my currant dissertation study titled
"Dyspnea Management and Quality of Life in Advanced Lung Cancer Patients".
I'm hoping that you can direct me in the process of utilizing this measurement tool.
Thank you,
Barbara A. Roces MSN, RN, NP
PhD Student
University of San Diego
BsMI Axeisson <bertil.ax0tesonQjll.se>
To: brocesQsanclego.edu

Tue, Oct 8, 2013 at 10:33 PM

Dear Ms Roces,
You are most welcome to use toe AQEL instrument in your study. As the original is in Swedish you are welcome
to come back to me if you find any of the wording suboptimal. A Dyspnea clinic in UK has used it like this and
another researcher in Ireland is also running a clinical study right now. Whan you enter the data into a statistical
program you have to be aware or that same of the questions have 10 as best and some the other way around.
Easiest is to add a formula to the specific column (11-X) meaning that you can still enter the exact number in the
questionnaire. Do not hesitate to mail me if you have further questions. I am already looking forward to read your
results.
Sincerely
Bertii Axeisson
MD. PhD
Dept of General Surgery, Ostersund Hospital
Dept of Radiation Sciences, University of Umefi
+46 70 580 56 51
Barbara R o o m <brocesQsandiego.edu> skriver
[Quoted text hidden]

*5 AQEL engelsfc versionTitd.pdf
“ 168K
Barbara R o o m <brocesQsandiego.edu>
To: Bertii Axeisson <bertii.axetesonQjn.se>

Wed. Oct 9,2013 at 8:18 AM

Deer Mr. Axeisson,
My greatest appreciation to you and your contribution to the medical science research. Thank you so much for
allowing me to use the AQEL instrument for my dissertation study. Ill be happy to email you my results.
Sincerely,
H p c /A n u t« o o (le £ ta V m u lM V ? a i> 2 a i» 7 g « 6 « M » 2 c A vew =.pt*<f«bei 1iU ic lM o o * 40 jUj e A q v ir u e A K U C h -q u e r y M * 14196062a0SS>75gAxxnt< !4196062>...

1/2
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APPEN D IX G
AQEL 20 - Quality of Life form
Before you fill in this form, we ask you to consider how things have been the past week. How you have
felt? What has been bothering? What has been good?
Sometimes things are better, sometimes worse. Try to weigh together how things have been and circle the
figure between 1 and 10 on the scale, which best corresponds with the last week. Do not ponder too long,
just circle the figure which spontaneously seems to agree to your state. Only circle one figure at each
question.

1. Approximately how many hours per day (8 a.m. to 8 p.m.) have you been lying down
1-------2-------3-------4------- 5------- 6------- 7------- 8------- 9------- 10
One hour at most

10 hours or more

2. How much help have you needed with dressing and hygiene?
1------ 2------ 3------- 4-------5-------6----- 7--------8--------9------ 10
No help at all

Help with

everything

3. How has your body strength been?
1------ 2------3------- 4------- 5-------6----- 7--------8--------9------ 10
None

As healthy

persons of same age

4. How much pain have you had during the last week?
1-------2------ 3------- 4-------5-------6----- 7------- 8--------9------ 10
Pain free

Worst possible pain

5. How much nausea have you had during the week?
1-------2------ 3--------4------- 5-------6----- 7--------8--------9------ 10
None

Worst possible

nausea

6. Have you had any trouble with your bowel movements?
1------ 2------ 3------- 4-------5-------6----- 7------- 8--------9------ 10
None

Worst possible

7. Have you felt breathlessness?
1-------2------ 3--------4-------5------- 6----- 7--------8------- 9------ 10
None

8. Have you been able to do what you like to do last week?

Worst possible
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1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Not at all

Yes, completely

9. How has your memory been for things lately?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Have had great difficulty in remembering

No problem in

remembering

10. Have you felt worried?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Not worried at all

Very worried

11. Have you had difficulty sleeping?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
None at all

Very difficult

12. How has your ability to concentrate been?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Very bad

Very good

13. Have you felt depressed/low in mood?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Not at all

Very

depressed/low in mood

14. How much of your worries have you shared with any member of your family?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Nothing

Everything

15. Have your friends regarded you as usual?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Not at all

Completely as

usual

16. Has your day felt meaningful?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Not at all

Completely

17. Has anything made you happy last week?
1-------2-------3------ 4-------5--------6-------7-------8-------9------ 10
Nothing

A lot
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18. How easy/hard has it been to get a hold of medical staff who know you when it has
been needed?
1------ 2-------3-------4-------5-------6------ 7—-—

g

—

— 9------ 10
Very hard

Very easy

19. Have you received the medical care you have needed?
1------ 2-------3-------4------ 5-------6-------7—-—

8— — 9------ 10
Completely

Not at all

20. How has your quality of life been last week?
1------ 2-------3-------4-------5-------6------ 7—•— 8— — 9- ----- 10
Very poor

Best possible

21. Has anything especially pleasant or unpleasant happened during the last week? In
your family? With your disease? Write a couple of lines to explain.

Reference
Qual Life Res (2010) 19:739-750
DOI 10.1007/sl 1136-010-9623-7
(Springer)
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10/17/14

The Uoivenjty of Sea Diego Mail - Ckacer Dppooea Scale

A Univcrsmw San Diego-

Cancer Dyspnoea Scale
BariMn Rocm <broc8C@sandiego.8du>
To. bjc@bicancsr.net

Sat, Sap 28,2013 at 6:37 PM

OMrEdtor-to-OM,

My mine is Bvbari A. Rocm a 3rt year PhD student r Nmlng to Univenly of San Diago. rm
intoreatod In w hg tw C m * DyspnM S c * h r m)r c u n n t dtaartafen study Sfcd ’Dyspnea
Managemant and Quaiy of LfcnAKancad long Concur P a w * -. She* taBJCpuM slwd dearth*
batow, I w o rt fce to ask panitolon to u m *» COS measurement icak.
rmhoptoa that you can (tract ma in toaprocaaa ct Jfclngthta maw jam ant toot
Sncanly.

BartaraA.RocaaMSN.RN.NP
H f) Student
Unirerstyot San Diego
Br J Cancar. 2000 February 82(4). 800-805
dot 10.1054/bjoc.1999.1002
PMCIO; PMC2374383

Development and validation of the Cancer Dyspnoea Scale: a
multidimensional, brief, self-rating scale
K Tanaka, 1,2 T Akechi.1,4 T Okuyam a, 1 Y Nishiwaki,2 and Y Uchitomil.3

b|c <bjc6bjcancer.net>
To; 8atbam Races <brocaa§sandl8go.8du>

Wad. Oct 2,2013 at 2:14 AM

Dear Barbara,

Sony for the delay in replying. That is fine to use the CDS measurement scale in your dissertation, you just
need to fuNy reference it in your work.

Best wishes

Nlldd Moran
IX4>cAnul4QO|te,c<aitaiMy?iii*2Ato7M6al692cJn«w*|W^c«crdyqMau1fcfeiJtos:netbcaicb«qKnAifel4i473cf4463e2iMbiBt«14t673cf44... 1/2
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APPEN D IX I

The C ancer Dyspnea Scale
We would like to ask you about your breathlessness or difficulty in breathing. Please answer each question
by circling only the numbers that best describes the breathing difficulty that you felt during the last few
days. Base your response on your first impression.

1. Can you inhale easily?
Not at All
A little
Much

Somewhat

Considerably

Very

2. Can you exhale easily?
Not at All
A little
Much

Somewhat

Considerably

Very

3. Can you breathe slowly?
Not at All
A little
Much

Somewhat

Considerably

Very

4. Do you feel short of breath?
Not at All
A little
Much

Somewhat

Considerably

Very

5. Do you feel breathing difficulty accompanied by palpitations and sweating?
Not at All
A little
Somewhat
Considerably
Very
Much
6. Do you feel as if you are panting?
Not at All
A little
Somewhat
Much

Considerably

Very

7. Do you feel such breathing difficulties that you don’t know what to do about it?
Not at All
A little
Somewhat
Considerably
Very
Much
8. Do you feel your breath is shallow?
Not at All
A little
Somewhat
Much

Considerably

Very

9. Do you feel your breathing may stop?
Not at All
A little
Somewhat
Much

Considerably

Very
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10. Do you feel your airway has become narrower?
Not at All
A little
Somewhat
Much

Considerably

Very

11. Do you feel as if you are drowning?
Not at All
A little
Somewhat
Much

Considerably

Very

12. Do you feel as if something is stuck in your airway?
Not at All
A little
Somewhat
Considerably
Much

Very

Calculation Method

1. Add the scores for each factor together
a. Factor 1 = (items 4+6+8+10+12) - 5
b. Factor 2 = (items 5+7+9+11) - 4
c. Factor 3 = 15- (items 1+2+3)
2. Add the total scores for each factor together
Reference:
British Journal o f Cancer (2000) 82(4), 800-805. © 2000 Cancer Research Campaign

